1. Home
  2. FUSB vs CYPH Comparison

FUSB vs CYPH Comparison

Compare FUSB & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First US Bancshares Inc.

FUSB

First US Bancshares Inc.

N/A

Current Price

$16.75

Market Cap

90.1M

Sector

Finance

ML Signal

N/A

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$0.63

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FUSB
CYPH
Founded
1952
2011
Country
United States
United States
Employees
N/A
6
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.1M
73.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FUSB
CYPH
Price
$16.75
$0.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3K
6.3M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.47
$0.49
52 Week High
$16.50
$3.70

Technical Indicators

Market Signals
Indicator
FUSB
CYPH
Relative Strength Index (RSI) 60.91 39.95
Support Level $15.75 $0.54
Resistance Level N/A $0.81
Average True Range (ATR) 0.19 0.09
MACD 0.02 -0.01
Stochastic Oscillator 100.00 20.44

Price Performance

Historical Comparison
FUSB
CYPH

About FUSB First US Bancshares Inc.

First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement accounts, and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: